Glucosio Galenica Senese (Glucose Monohydrate)

Glucosio Galenica Senese is employed in clinical settings where rapid glucose delivery and fluid balance are required.

• Management of hypoglycemia when oral intake is not feasible.
• Component of total parenteral nutrition regimens for patients unable to receive enteral feeding.
• Fluid and electrolyte replacement in peri‑operative or trauma care.
• Support for patients with metabolic disorders that limit endogenous glucose production.
• Adjunct in drug dilution for intravenous infusion when a glucose carrier is needed.

Intravenous administration of glucose monohydrate can be associated with a range of observed effects, most of which are related to the metabolic and osmotic properties of the solution.

Common

• Transient hyperglycemia that resolves as glucose is metabolized.
• Mild irritation at the injection site or peripheral vein.
• Electrolyte shifts, particularly a temporary decrease in serum potassium.
• Fluid overload in patients with compromised cardiac function.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypotension from rapid infusion of large volumes.
• Acute metabolic acidosis in patients with impaired lactate clearance.

When using Glucosio Galenica Senese, clinicians should observe several precautionary measures to minimise risks and ensure appropriate patient monitoring.

• Verify blood glucose level before and after infusion.
• Adjust infusion rate in patients with heart failure or renal insufficiency.
• Use aseptic technique to prevent catheter‑related infections.
• Monitor electrolytes, especially potassium and sodium, during therapy.
• Avoid administration to patients with known hypersensitivity to glucose solutions.
• Consider compatibility with other intravenous drugs before co‑infusion.

Glucose monohydrate solutions may interact with other intravenously administered agents, influencing their efficacy or safety profile.

Avoid

• Co‑administration with high‑dose insulin without glucose monitoring.
• Simultaneous infusion of potassium chloride in concentrations that exceed recommended limits.
• Mixing with medications that are unstable in hyperosmolar environments (e.g., certain antibiotics).

Use with caution

• Concurrent use of diuretics that may exacerbate electrolyte disturbances.
• Administration alongside catecholamines, which can increase glucose production.
• Infusion with blood products that contain citrate, potentially affecting calcium balance.